161 related articles for article (PubMed ID: 12969869)
1. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.
Ordoñez CL; Henig NR; Mayer-Hamblett N; Accurso FJ; Burns JL; Chmiel JF; Daines CL; Gibson RL; McNamara S; Retsch-Bogart GZ; Zeitlin PL; Aitken ML
Am J Respir Crit Care Med; 2003 Dec; 168(12):1471-5. PubMed ID: 12969869
[TBL] [Abstract][Full Text] [Related]
2. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K
Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395
[TBL] [Abstract][Full Text] [Related]
4. Duration of effect of intravenous antibiotics on spirometry and sputum cytokines in children with cystic fibrosis.
Cunningham S; McColm JR; Mallinson A; Boyd I; Marshall TG
Pediatr Pulmonol; 2003 Jul; 36(1):43-8. PubMed ID: 12772222
[TBL] [Abstract][Full Text] [Related]
5. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
6. Safety and use of sputum induction in children with cystic fibrosis.
Suri R; Marshall LJ; Wallis C; Metcalfe C; Shute JK; Bush A
Pediatr Pulmonol; 2003 Apr; 35(4):309-13. PubMed ID: 12629630
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A(4) and interleukin-8 levels in cystic fibrosis sputum after antibiotherapy.
Chiron R; Grumbach YY; Quynh NV; Verriere V; Urbach V
J Cyst Fibros; 2008 Nov; 7(6):463-8. PubMed ID: 18541460
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation.
Downey DG; Brockbank S; Martin SL; Ennis M; Elborn JS
Pediatr Pulmonol; 2007 Aug; 42(8):729-35. PubMed ID: 17588254
[TBL] [Abstract][Full Text] [Related]
9. Induced sputum in cystic fibrosis: within-week reproducibility of inflammatory markers.
Smountas AA; Lands LC; Mohammed SR; Grey V
Clin Biochem; 2004 Nov; 37(11):1031-6. PubMed ID: 15498533
[TBL] [Abstract][Full Text] [Related]
10. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis.
Ordoñez CL; Kartashov AI; Wohl ME
J Pediatr; 2004 Nov; 145(5):689-92. PubMed ID: 15520781
[TBL] [Abstract][Full Text] [Related]
11. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
[TBL] [Abstract][Full Text] [Related]
12. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
[TBL] [Abstract][Full Text] [Related]
14. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
Cahen P; Le Bourgeois M; Delacourt C; Coustère C; Nicaise P; de Blic J; Véron M; Scheinmann P; Gaillard JL
Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
[TBL] [Abstract][Full Text] [Related]
15. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.
Sagel SD; Sontag MK; Wagener JS; Kapsner RK; Osberg I; Accurso FJ
J Pediatr; 2002 Dec; 141(6):811-7. PubMed ID: 12461498
[TBL] [Abstract][Full Text] [Related]
16. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone.
Regelmann WE; Elliott GR; Warwick WJ; Clawson CC
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):914-21. PubMed ID: 2109558
[TBL] [Abstract][Full Text] [Related]
17. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis.
Downey DG; Martin SL; Dempster M; Moore JE; Keogan MT; Starcher B; Edgar J; Bilton D; Elborn JS
Pediatr Pulmonol; 2007 Mar; 42(3):216-20. PubMed ID: 17238189
[TBL] [Abstract][Full Text] [Related]
18. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
19. Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma.
Bacci E; Cianchetti S; Paggiaro PL; Carnevali S; Bancalari L; Dente FL; Di Franco A; Giannini D; Vagaggini B; Giuntini C
Clin Exp Allergy; 1996 Dec; 26(12):1395-400. PubMed ID: 9027440
[TBL] [Abstract][Full Text] [Related]
20. In celebration of expectoration: induced sputum indices as outcome measures in cystic fibrosis.
Armstrong DS
Am J Respir Crit Care Med; 2003 Dec; 168(12):1412-3. PubMed ID: 14668253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
